Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01210027 · ClinicalTrials.gov registry record
A Study of Radiation Toxicity in the Liver Using MRI-Based Perfusion
A clinical trial, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- 143
- Enrollment target
NCT01210027 is a clinical trial that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 143 participants.
The verdict
NCT01210027 has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- 143 participants
- Enrollment target
Study Summary
Researchers at the the University of Michigan are conducting a research project to assess how a course of radiation therapy changes the way blood flows through the liver. To be able to do this, the researchers will be using MRI (magnetic resonance imaging) scans completed before, during, and after radiation therapy. MRI's will be done on 4 or 5 occasions. On each occasion, you will be injected with a fluid called gadolinium (a contrast agent) before getting an MRI. This contrast agent makes it easier for the Researchers to see your organs in the scans, and causes any abnormal areas to become very bright on the MRI. This agent will be injected into a vein in your arm or leg. Each MRI scan will last approximately 45 minutes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 143 participants |
| Start Date | 2007-03 |
| Est. Completion | 2023-04-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01210027
The ClinicalTrials.gov registry entry for NCT01210027 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 143 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01210027 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01210027 about?
NCT01210027 is a clinical study titled "A Study of Radiation Toxicity in the Liver Using MRI-Based Perfusion". Researchers at the the University of Michigan are conducting a research project to assess how a course of radiation therapy changes the way blood flows through the liver. To be able to do this, the researchers will be using MRI (magnetic resonance imaging) scans completed before, during, and after r...
What is the current status of trial NCT01210027?
This trial is currently completed. The enrollment target is 143 participants. The study started on 2007-03. Estimated completion is 2023-04-01.
Who is sponsoring clinical trial NCT01210027?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.